Mint Tower Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Mint Tower Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$52K	–	312
2019 Q4	$52K	Hold	5,000	–	–	0.01%	212
2019 Q3	$20K	Hold	5,000	–	–	﹤0.01%	174
2019 Q2	$74K	Hold	5,000	–	–	0.01%	218
2019 Q1	$2K	Buy	+5,000	New	+$125K	﹤0.01%	184
2018 Q4	–	Sell	-5,000	Closed	-$147K	–	243
2018 Q3	$147K	Hold	5,000	–	–	0.02%	171
2018 Q2	$227K	Buy	+5,000	New	+$243K	0.03%	183

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Mint Tower Capital Management's CLVS Position: Q1 2020 in Review

Mint Tower Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 2,000 shares — an estimated $21K sold.

Mint Tower Capital Management first reported a position in CLVS in Q2 2019 and held it in 3 quarters. The position peaked at $28K in Q2 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

Mint Tower Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
Mint Tower Capital Management sold 2,000 Clovis Oncology, Inc. shares in Q1 2020, an estimated $21K.
Mint Tower Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 3 quarters.
Mint Tower Capital Management's Clovis Oncology, Inc. position peaked at $28K in Q2 2019.
154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on Mint Tower Capital Management's 13F filing for Q1 2020, filed 13 May 2020.